Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Kuruvilla
Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients With Advanced Solid Tumors or Lymphoma
Clinical Cancer Research
Cancer Research
Oncology
Updates From the 2017 American Society of Hematology Annual Meeting: Practice-Changing Studies in Relapsed and Refractory Mantle Cell Lymphoma
Current Oncology
Oncology
Phase 1b Study of Pembrolizumab in Patients With Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (Rrpmbcl): Updated Results From the Keynote-013 Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Efficiency and Safety of Stem Cell Mobilization Following GDP Salvage in Patients With Relapsed or Refractory Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Functional Predictors of Chemotherapy Toxicity in Elderly Lymphoma Patients - A Prospective Pilot Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Phase 1b Keynote-013 Study of Pembrolizumab in Patients With Classic Hodgkin Lymphoma After Brentuximab Vedotin Failure: Results of >4 Years of Follow-Up
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Nivolumab for Relapsed/Refractory Classical Hodgkin Lymphoma After Autologous Transplant: Full Results After Extended Follow-Up of the Phase 2 Checkmate 205 Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase 2 Checkmate 436 Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Characteristics and Outcomes of Patients With Relapsed Follicular Lymphoma Following Retreatment With Second-Line Rituximab-Containing Chemotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
